Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan - PubMed (original) (raw)
. 1984 Mar;132(3):1479-86.
- PMID: 6198393
Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan
E Razin et al. J Immunol. 1984 Mar.
Abstract
Mouse mast cells were differentiated and grown by culturing bone marrow cells in medium containing 2 X 10(-10) M purified interleukin 3 (IL 3). The cells obtained were similar in ultrastructure, membrane antigen phenotype, proteoglycan type, and lipid products generated upon immunologic activation to mast cells differentiated in culture by WEHI-3-conditioned medium (WEHI-3-CM) and by concanavalin A (Con A) splenocyte-conditioned medium. Phenotypically, these cells expressed IgE receptors and H-2 antigens and were recognized by a monoclonal antibody (B23.1) that did not react with mouse serosal heparin-containing mast cells. The classic phenotypic markers of mouse T cells or macrophages were not detected. The mouse mast cells differentiated with IL 3 as well as those differentiated in WEHI-3-CM incorporated [35S]sulfate into a nonheparin proteoglycan of 150,000 to 200,000 m.w. Most of the 35S-labeled macromolecules were degraded by chondroitinase ABC to yield only two disaccharides, which co-chromatographed on ascending thin layer chromatography with delta Di-4S and delta Di-diSE; thus, the proteoglycan in these cells is composed of chondroitin sulfate E glycosaminoglycans. After sensitization with monoclonal IgE, washing, and antigen activation, the IL 3 differentiated cells released the preformed mediator beta-hexosaminidase and generated and released two major classes of lipid mediators. The quantities of leukotriene C4 (LTC4), leukotriene B4 (LTB4), and platelet-activating factor (PAF-acether) generated/10(6) cells were 17, 3.0, and 3.1 ng, respectively. The ratio of these three lipid mediators was similar to that obtained from mast cells differentiated in WEHI-3-CM and in Con A-conditioned medium. Thus, T cell-derived IL 3 is the component present in the conditioned media that is required for differentiation and growth of the subclass of mast cells containing chondroitin sulfate E proteoglycan, designated E-MC. The IL 3-dependent E-MC may represent the in vitro counterpart of the T-cell-dependent mucosal mast cell, suggesting in turn that the production of LTC4 and LTB4 and of PAF-acether may play a role in adaptive intestinal immunity to helminthic parasites.
Similar articles
- Inhibition of proliferation of mouse T cell-dependent bone marrow-derived mast cells by rat serum does not change their unique phenotype.
Stevens RL, Bloes WF, Seldin DC, Razin E, Katz HR, Austen KF. Stevens RL, et al. J Immunol. 1984 Nov;133(5):2674-80. J Immunol. 1984. PMID: 6332858 - IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
Razin E, Mencia-Huerta JM, Stevens RL, Lewis RA, Liu FT, Corey E, Austen KF. Razin E, et al. J Exp Med. 1983 Jan 1;157(1):189-201. doi: 10.1084/jem.157.1.189. J Exp Med. 1983. PMID: 6184439 Free PMC article. - Ontogeny of in vitro-differentiated mouse mast cells.
Stevens RL, Rothenberg ME, Levi-Schaffer F, Austen KF. Stevens RL, et al. Fed Proc. 1987 Apr;46(5):1915-9. Fed Proc. 1987. PMID: 3549363 Review. - Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
Kay AB. Kay AB. Eur J Respir Dis Suppl. 1983;129:1-44. Eur J Respir Dis Suppl. 1983. PMID: 6418559 Review.
Cited by
- Cultured human bone marrow-derived mast cells, their similarities to cultured murine E-mast cells.
Gilead L, Rahamim E, Ziv I, Or R, Razin E. Gilead L, et al. Immunology. 1988 Apr;63(4):669-75. Immunology. 1988. PMID: 3130309 Free PMC article. - Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells.
Nakano T, Sonoda T, Hayashi C, Yamatodani A, Kanayama Y, Yamamura T, Asai H, Yonezawa T, Kitamura Y, Galli SJ. Nakano T, et al. J Exp Med. 1985 Sep 1;162(3):1025-43. doi: 10.1084/jem.162.3.1025. J Exp Med. 1985. PMID: 3897446 Free PMC article. - Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B.
Uehara T, Bléry M, Kang DW, Chen CC, Ho LH, Gartland GL, Liu FT, Vivier E, Cooper MD, Kubagawa H. Uehara T, et al. J Clin Invest. 2001 Oct;108(7):1041-50. doi: 10.1172/JCI12195. J Clin Invest. 2001. PMID: 11581305 Free PMC article. - Loss of TRPC1-mediated Ca2+ influx contributes to impaired degranulation in Fyn-deficient mouse bone marrow-derived mast cells.
Suzuki R, Liu X, Olivera A, Aguiniga L, Yamashita Y, Blank U, Ambudkar I, Rivera J. Suzuki R, et al. J Leukoc Biol. 2010 Nov;88(5):863-75. doi: 10.1189/jlb.0510253. Epub 2010 Jun 22. J Leukoc Biol. 2010. PMID: 20571036 Free PMC article. - Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells.
Wagelie-Steffen AL, Hartmann K, Vliagoftis H, Metcalfe DD. Wagelie-Steffen AL, et al. Immunology. 1998 Aug;94(4):569-74. doi: 10.1046/j.1365-2567.1998.00559.x. Immunology. 1998. PMID: 9767446 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous